<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ella Navarro, Author at UK Investor Magazine</title>
	<atom:link href="https://ukinvestor.foxrobinson.com/author/ella-navarro/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestor.foxrobinson.com/author/ella-navarro/</link>
	<description></description>
	<lastBuildDate>Mon, 26 Feb 2018 15:41:35 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.3</generator>
	<item>
		<title>Destiny Pharma announces FDA approval for new drug application</title>
		<link>https://ukinvestor.foxrobinson.com/destiny-pharma-announces-new-drug-application/</link>
					<comments>https://ukinvestor.foxrobinson.com/destiny-pharma-announces-new-drug-application/#comments</comments>
		
		<dc:creator><![CDATA[Ella Navarro]]></dc:creator>
		<pubDate>Mon, 26 Feb 2018 14:36:59 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=10471</guid>

					<description><![CDATA[<img width="300" height="229" src="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/shutterstock_1018962748-300x229.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/shutterstock_1018962748-300x229.jpg 300w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/shutterstock_1018962748-768x586.jpg 768w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/shutterstock_1018962748-550x420.jpg 550w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/shutterstock_1018962748-80x60.jpg 80w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/shutterstock_1018962748-100x75.jpg 100w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/shutterstock_1018962748-640x488.jpg 640w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/shutterstock_1018962748-681x520.jpg 681w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/shutterstock_1018962748.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Destiny Pharma (LON:DEST) announced Monday they are commencing US clinical trials for its novel anti-infective drug XF-73, after the FDA accepted the Investigational New Drug application. The anti-infective drug is being developed to prevent post-surgical staphylococcal infections in patients such as Methicillin Resistant Staphylococcus aureus (MRSA). “We are pleased to open the IND and are [&#8230;]</p>
<p>The post <a href="https://ukinvestor.foxrobinson.com/destiny-pharma-announces-new-drug-application/">Destiny Pharma announces FDA approval for new drug application</a> appeared first on <a href="https://ukinvestor.foxrobinson.com">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestor.foxrobinson.com/destiny-pharma-announces-new-drug-application/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>Hilton Food extends meat supply contract with Australian supermarket Woolworths</title>
		<link>https://ukinvestor.foxrobinson.com/hilton-food-agrees-restructure/</link>
					<comments>https://ukinvestor.foxrobinson.com/hilton-food-agrees-restructure/#respond</comments>
		
		<dc:creator><![CDATA[Ella Navarro]]></dc:creator>
		<pubDate>Mon, 26 Feb 2018 12:22:47 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=10462</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/hilton-foods-woolworths-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="hilton foods, woolworths" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/hilton-foods-woolworths-300x200.jpg 300w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/hilton-foods-woolworths-768x512.jpg 768w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/hilton-foods-woolworths-630x420.jpg 630w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/hilton-foods-woolworths-537x360.jpg 537w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/hilton-foods-woolworths-640x427.jpg 640w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/hilton-foods-woolworths-681x454.jpg 681w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/02/hilton-foods-woolworths.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Hilton Food Group (LON:HFG) announced Monday they have agreed to extend for 15 years the meat supply agreement with Australian supermarket Woolworths. The supply, by Hilton Foods Australia, will include packaged and value-added meat products. It is expected to start operations in the plants of Bunbury and Truganina from the 1st of July this year. [&#8230;]</p>
<p>The post <a href="https://ukinvestor.foxrobinson.com/hilton-food-agrees-restructure/">Hilton Food extends meat supply contract with Australian supermarket Woolworths</a> appeared first on <a href="https://ukinvestor.foxrobinson.com">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestor.foxrobinson.com/hilton-food-agrees-restructure/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Concepta announces positive outcome from myLotus testing in China</title>
		<link>https://ukinvestor.foxrobinson.com/concepta-positive-outcome-mylotus-testing-china/</link>
					<comments>https://ukinvestor.foxrobinson.com/concepta-positive-outcome-mylotus-testing-china/#respond</comments>
		
		<dc:creator><![CDATA[Ella Navarro]]></dc:creator>
		<pubDate>Mon, 29 Jan 2018 13:22:28 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=10169</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/concepta-pregnancy-china-mylotus-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" srcset="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/concepta-pregnancy-china-mylotus-300x200.jpg 300w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/concepta-pregnancy-china-mylotus-768x512.jpg 768w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/concepta-pregnancy-china-mylotus-630x420.jpg 630w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/concepta-pregnancy-china-mylotus-537x360.jpg 537w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/concepta-pregnancy-china-mylotus-640x427.jpg 640w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/concepta-pregnancy-china-mylotus-681x454.jpg 681w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/concepta-pregnancy-china-mylotus.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>Concepta plc (LON: CPT) announced positive results from the hospital evaluations executed in China on its fertility product myLotus. Concepta&#8217;s product is an alternative to blood testing in the China&#8217;s overloaded hospitals. MyLotus allows women to check for pregnancy and ovulation signs at home instead of seeking consultation at the hospital. The results showed that [&#8230;]</p>
<p>The post <a href="https://ukinvestor.foxrobinson.com/concepta-positive-outcome-mylotus-testing-china/">Concepta announces positive outcome from myLotus testing in China</a> appeared first on <a href="https://ukinvestor.foxrobinson.com">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestor.foxrobinson.com/concepta-positive-outcome-mylotus-testing-china/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Eurozone economy still needs support says ECB President Mario Draghi</title>
		<link>https://ukinvestor.foxrobinson.com/eurozone-economy-still-needs-support-says-ecb-president-mario-draghi/</link>
					<comments>https://ukinvestor.foxrobinson.com/eurozone-economy-still-needs-support-says-ecb-president-mario-draghi/#respond</comments>
		
		<dc:creator><![CDATA[Ella Navarro]]></dc:creator>
		<pubDate>Thu, 25 Jan 2018 15:06:10 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=10160</guid>

					<description><![CDATA[<img width="300" height="200" src="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/mario-draghi-european-central-bank-300x200.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/mario-draghi-european-central-bank-300x200.jpg 300w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/mario-draghi-european-central-bank-768x512.jpg 768w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/mario-draghi-european-central-bank-630x420.jpg 630w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/mario-draghi-european-central-bank-537x360.jpg 537w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/mario-draghi-european-central-bank-640x427.jpg 640w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/mario-draghi-european-central-bank-681x454.jpg 681w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/mario-draghi-european-central-bank.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>The recent volatility in the Euro &#8220;needs monitoring&#8221; but &#8220;by and large the risks to growth are balanced,” said European Central Bank president Mario Draghi at the press conference following the ECB&#8217;s rate decision. The central bank confirmed key interest rates will remain unchanged at record lows, inline with market expectations. In addition, Draghi said [&#8230;]</p>
<p>The post <a href="https://ukinvestor.foxrobinson.com/eurozone-economy-still-needs-support-says-ecb-president-mario-draghi/">Eurozone economy still needs support says ECB President Mario Draghi</a> appeared first on <a href="https://ukinvestor.foxrobinson.com">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestor.foxrobinson.com/eurozone-economy-still-needs-support-says-ecb-president-mario-draghi/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>IntegraFin will be the first company to float on LSE in 2018</title>
		<link>https://ukinvestor.foxrobinson.com/fintech-integrafin-float-london-stock-exchange/</link>
					<comments>https://ukinvestor.foxrobinson.com/fintech-integrafin-float-london-stock-exchange/#respond</comments>
		
		<dc:creator><![CDATA[Ella Navarro]]></dc:creator>
		<pubDate>Tue, 23 Jan 2018 15:25:28 +0000</pubDate>
				<category><![CDATA[Shares]]></category>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=10131</guid>

					<description><![CDATA[<img width="300" height="220" src="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/integrafin-fintech-transact-300x220.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="" style="display: block; margin: auto; margin-bottom: 5px;max-width: 100%;" link_thumbnail="" decoding="async" loading="lazy" srcset="https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/integrafin-fintech-transact-300x220.jpg 300w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/integrafin-fintech-transact-768x562.jpg 768w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/integrafin-fintech-transact-574x420.jpg 574w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/integrafin-fintech-transact-80x60.jpg 80w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/integrafin-fintech-transact-640x468.jpg 640w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/integrafin-fintech-transact-681x498.jpg 681w, https://ukinvestor.foxrobinson.com/wp-content/uploads/2018/01/integrafin-fintech-transact.jpg 1000w" sizes="(max-width: 300px) 100vw, 300px" /><p>The Fintech company IntegraFin Holdings announced yesterday their intention to float in the London Stock Exchange, details of the disclosure valued the company at an estimated of £500m. The finance software advice company emerged as one of the first companies in the sector to declare a London listing this year, after years of speculation. &#8220;We [&#8230;]</p>
<p>The post <a href="https://ukinvestor.foxrobinson.com/fintech-integrafin-float-london-stock-exchange/">IntegraFin will be the first company to float on LSE in 2018</a> appeared first on <a href="https://ukinvestor.foxrobinson.com">UK Investor Magazine</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ukinvestor.foxrobinson.com/fintech-integrafin-float-london-stock-exchange/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
